Sanofi Pasteur publishes results of phase III dengue vaccine efficacy study
88.5 per cent reduction of dengue haemorrhagic fever shown in detailed analyses
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.